FIELD: gynecology. SUBSTANCE: method consists in that estrogen or estrogen with progestin is administered every day without break in doses blocking folliculogenesis. At at least one month intervals, menstruation is stimulated by administering antiprogestin in doses efficient to reject accumulated endometrial tissue. Adequate pharmaceutical compositions and drug sets are provided. EFFECT: eliminated sudden uterine bleeding caused by small estrogen doses. 48 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HORMONAL SUBSTITUTIONAL THERAPY | 1994 |
|
RU2139056C1 |
| METHOD OF PREVENTING AND DELAYING FECUNDATION | 1994 |
|
RU2139055C1 |
| CONTRACEPTION METHOD FOR BEING USED BY WOMEN OF REPRODUCTIVE PERIOD NOT ACCESSING PREMENOPAUSAL PERIOD | 1994 |
|
RU2169567C2 |
| PHARMACEUTICAL COMBINED PREPARATION FOR HORMONAL CONTRACEPTION | 1996 |
|
RU2165259C2 |
| ORAL CONTRACEPTIVES FOR PREVENTION PREGNANCY AND REDUCTION OF PREMENSTRUAL SYMPTOMATOLOGY | 2002 |
|
RU2351339C2 |
| PHARMACEUTICAL COMBINED PREPARATION FOR HORMONAL CONTRACEPTION | 1995 |
|
RU2165258C2 |
| SCHEME FOR GESTAGEN-ANTIGESTAGEN INTAKE | 1998 |
|
RU2215540C2 |
| THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
| INTRAVAGINAL DRUG DELIVERY DEVICE | 2011 |
|
RU2648827C2 |
| PROGESTERONE ANTAGONISTS FOR PREPARING DRUGS USED IN TREATMENT OF PATIENTS WITH DISFUNCTIONAL UTERINE BLEEDING | 1995 |
|
RU2170580C2 |
